{
    "Case ID": "080010",
    "Crime_Name": [
        "Intellectual Property Dispute"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent Listing Dispute"
    ],
    "Legal_Issue": [
        "Whether Apotex must address AstraZeneca's '762 Patent under the NOC Regulations"
    ],
    "Governing_Law": [
        "NOC Regulations"
    ],
    "Procedural_Stage": [
        "Judicial Review"
    ],
    "Evidence_Assessment": [
        "Timing of marketing post-NOC issuance, product specificity of the patent"
    ],
    "Decision_Outcome": [
        "Apotex must address the '762 Patent"
    ],
    "Burden_of_Proof": [
        "On Apotex to demonstrate improper listing"
    ],
    "Credibility_Factor": [],
    "Legal_Rule": [
        "Subsection 5(1) of the NOC Regulations requires generic manufacturers to address patents listed on the register if the drug was marketed in Canada pursuant to an NOC"
    ],
    "Standard_of_Review": [
        "Reasonableness"
    ],
    "Procedural_Issue": [
        "Challenge to the Minister's decision on patent listing"
    ],
    "Grounds_for_Claim": [
        "Improper listing of the '762 Patent due to timing and product specificity"
    ],
    "Outcome_on_Merits": [
        "Application dismissed with costs"
    ],
    "Decision_Maker": [
        "Court"
    ],
    "Judicial_Review_Outcome": [
        "Dismissed"
    ],
    "Review_Standard": [
        "Reasonableness"
    ],
    "Procedural_Fairness_Assessment": [
        "Not explicitly addressed"
    ],
    "Key_Evidence_Considered": [
        "AstraZeneca's listing of the '762 Patent against multiple NOCs, marketing timeline"
    ],
    "Legal_Framework": [
        "Regulatory framework for patent listing under NOC Regulations"
    ],
    "Applicant_Challenge": [
        "Apotex challenged the Minister's requirement to address the '762 Patent"
    ],
    "Court_Result": [
        "Dismissed Apotex's application"
    ],
    "Legal_Rule_Source": [
        "NOC Regulations, subsection 5(1)"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Minister contended that marketing occurred post-NOC issuance, triggering regulatory obligations"
    ],
    "Evidence_Type": [
        "Regulatory filings, patent register entries, NOC records"
    ],
    "Remedy_Requested": [
        "Judicial review of the Minister's decision"
    ],
    "Outcome": [
        "Apotex required to address the '762 Patent"
    ],
    "Decision_Authority": [
        "Federal Court"
    ],
    "Remedy_Sought": [
        "Set aside the Minister's decision"
    ],
    "Resolution_Mechanism": [
        "Judicial review"
    ],
    "Legal_Provision": [
        "NOC Regulations, subsection 5(1)"
    ],
    "Authority": [
        "Minister of Health"
    ],
    "Claimant_Status": [
        "Apotex as applicant"
    ],
    "Legal_Provision_Cited": [
        "NOC Regulations s. 5(1)"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Improper patent listing"
    ],
    "Applicable_Process": [
        "Judicial review under NOC Regulations"
    ],
    "Outcome_of_Review": [
        "Application dismissed"
    ],
    "Pending_Relief_or_Application": [
        "None â€“ application concluded"
    ],
    "Jurisdiction": [
        "Federal jurisdiction, Canada"
    ],
    "Governing_Rule": [
        "NOC Regulations"
    ]
}